HOME > ARCHIVE
ARCHIVE
- BULLETIN
November 10, 2003
- WORLD NEWS IN BRIEF
November 10, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
November 10, 2003
- Japanese Healthcare Q&A (3)
November 10, 2003
- Hayashibara Develops Peptide Antigens for Transmucosal Administration
November 10, 2003
- Nearly 70% of Women Worry about Adverse Reactions of Oral Contraceptives
November 10, 2003
- Long-term Monitoring Required after H. Pylori Eradication
November 10, 2003
- Debiopharm Preparing to Enter Japanese Market: Dr Mauvernay
November 10, 2003
- Crucial Info Should Be Printed Larger on Drug Labels: Study
November 10, 2003
- FJPWA Management Seminar
November 10, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
November 10, 2003
- Camurus Proposes to Use Its DDS Technology to Develop "Super Generics": Dr Westrin
November 3, 2003
- AdvaMed, ACCJ Submit Recommendation on Medical Device Industry
November 3, 2003
- Wholesalers See Record-low Gross Profit Ratio in FY2002: FJPWA Survey
November 3, 2003
- Korosho to Help Hospitals Set Up "Medical Device Management Offices"
November 3, 2003
- Oriental Yeast, SPI Tie Up on Contract Cell Culture
November 3, 2003
- GEYMS: Bone Density Meter DPX-BRAVO
November 3, 2003
- Nippon Shinyaku Licenses NS-220, Blood Lipid Metabolism Improver, to Roche
November 3, 2003
- Olympus: EVIS LUCERA Multipurpose Videoscope
November 3, 2003
- Takeda to Restructure Domestic Production System
November 3, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
